Wall Street Analysts Predict a 61.05% Upside in SpringWorks Therapeutics (SWTX): Here's What You Should Know

SpringWorks Therapeutics (SWTX) closed the last trading session at $40.98, gaining 20.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $66 indicates a 61.1% upside potential. The average comprises eight short-term price targets ranging from a low of $52 to a high of $77, with a standard deviation of $9.13. While the lowest estimate indicates an increase of 26.9% from the current ...